Compared with repaglinide sulphonylurea treatment in type 2 diabetes is associated with a 2.5-fold increase in symptomatic hypoglycaemia with blood glucose levels < 2.5 mmol/l

✍ Scribed by JørgenSmedegaard Kristensen; KirstineBrown Frandsen; Thomas Bayer; Peter Müller

• Book ID: 117369801
• Publisher: Elsevier Science
• Year: 2000
• Tongue: English
• Weight: 128 KB
• Volume: 50
• Category: Article
• ISSN: 0168-8227
• DOI: 10.1016/s0168-8227(00)81703-9